Abstract:Background Age‐associated aortic remodeling includes a marked increase in intimal medial thickness (IMT), associated with signs of inflammation. Although aortic wall milk fat globule–epidermal growth factor VIII (MFG‐E8) increases with age, and is associated with aortic inflammation, it is not known whether MFG‐E8 is required for the age‐associated increase in aortic IMT. Here, we tested whether MFG‐E8 is required for the age‐associated increase in aortic IMT. Methods and Results To determine the role of MFG‐E8 in the age‐associated increase of IMT, we compared aortic remodeling in adult (20‐week) and aged (96‐week) MFG‐E8 (−/−) knockout and age matched wild‐type (WT) littermate mice. The average aortic IMT increased with age in the WT from 50±10 to 70±20 μm ( P <0.0001) but did not significantly increase with age in MFG‐E8 knockout mice. Because angiotensin II signaling is implicated as a driver of age‐associated increase in IMT, we infused 30‐week‐old MFG‐E8 knockout and age‐matched littermate WT mice with angiotensin II or saline via osmotic mini‐pumps to determine whether MFG‐E8 is required for angiotensin II–induced aortic remodeling. (1) In WT mice, angiotensin II infusion substantially increased IMT, elastic lamina degradation, collagen deposition, and the proliferation of vascular smooth muscle cells; in contrast, these effects were significantly reduced in MFG‐E8 KO mice; (2) On a molecular level, angiotensin II treatment significantly increased the activation and expression of matrix metalloproteinase type 2, transforming growth factor beta 1, and its downstream signaling molecule phosphorylated mother against decapentaplegic homolog 2, and collagen type I production in WT mice; however, in the MFG‐E8 knockout mice, these molecular effects were significantly reduced; and (3) in WT mice, angiotensin II increased levels of aortic inflammatory markers phosphorylated nuclear factor‐kappa beta p65, monocyte chemoattractant protein 1, tumor necrosis factor alpha, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 molecular expression, while in contrast, these inflammatory markers did not change in knockout mice. Conclusions Thus, MFG‐E8 is required for both age‐associated proinflammatory aortic remodeling and also for the angiotensin II–dependent induction in younger mice of an aortic inflammatory phenotype observed in advanced age. Targeting MFG‐E8 would be a novel molecular approach to curb adverse arterial remodeling. Nonstandard Abbreviations and Acronyms AT1 angiotensin II receptor type 1 AT2 angiotensin II receptor type 2 ICAM1 intercellular adhesion molecule 1 IMT intimal medial thickness MCP1 monocyte chemoattractant protein 1 MFG‐E8 milk fat globule–epidermal growth factor VIII MMP2 matrix metalloproteinase type 2 NF‐κB p65 nuclear factor‐kappa beta p65 p‐NF‐κB p65 phosphorylated nuclear factor‐kappa beta p65 SMAD2 mother against decapentaplegic homolog 2 TGF‐β1 transforming growth factor beta 1 TNF‐α tumor necrosis factor alpha VCAM1 vascular cell adhesion molecule 1 VSMC vascular smooth muscle cell WT wild‐type Clinical Perspective What Is New? Milk fat globule–epidermal growth factor 8 increases with age and is required for age‐associated proinflammatory arterial remodeling that results in aortic intimal medial thickening. In younger mice, milk fat globule–epidermal growth factor 8 is also essential for angiotensin II–induced adverse arterial remodeling that mimics that which occurs in advanced age via the increase of proinflammation, intimal medial thickeni -Abstract Truncated-

MFAP4-Deficiency Aggravates Age-Induced Changes in Resistance Artery Structure, While Ameliorating Hypertension

MFAP4 Deficiency Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm Formation Through Regulation of Macrophage Infiltration and Activity

Functional, Structural and Proteomic Effects of Ageing in Resistance Arteries

Deletion of Microfibrillar-Associated Protein 4 Attenuates Left Ventricular Remodeling and Dysfunction in Heart Failure.

The pro-resolving mediator, annexin A1 regulates blood pressure, and age-associated changes in cardiovascular function and remodeling

Aging impairs smooth muscle-mediated regulation of aortic stiffness: a defect in shock absorption function?

Abstract 548: Anti-aging Gene Klotho Deficiency Exacerbates High Fat Diet-induced Arterial Stiffening and Hypertension by Downregulation of AMP-activated Protein Kinase

Sex-specific phenotypes in the aging mouse heart and consequences for chronic fibrosis

Cellular Senescence Contributes to Large Elastic Artery Stiffening and Endothelial Dysfunction With Aging: Amelioration With Senolytic Treatment

Chronic angiotensin converting enzyme inhibition attenuates frailty and protects against atrial fibrillation in aging mice

MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation

Reduction of fibrosis-related arrhythmias by chronic renin-angiotensin-aldosterone system inhibitors in an aged mouse model

Aortic Artery Elastic Lamina Degradation, Collagen Remodeling, Oxides Stress and Inflammation in the Apolipoprotein E Deficient Mice with or Without Aortic Banding

Smooth Muscle Cell-Mineralocorticoid Receptor as a Mediator of Cardiovascular Stiffness With Aging

Inflammatory Role of Milk Fat Globule-Epidermal Growth Factor VIII in Age-Associated Arterial Remodeling.

Increased vascular smooth muscle cell senescence in aneurysmal Fibulin-4 mutant mice

Mkk4 is a negative regulator of the transforming growth factor beta 1 signaling associated with atrial remodeling and arrhythmogenesis with age.

Transmural Remodeling of Cardiac Microstructure in Aged Spontaneously Hypertensive Rats by Diffusion Tensor MRI

Aging related decreases in NM myosin expression and contractility in a resistance vessel

Extracellular Matrix Disarray As A Mechanism For Greater Abdominal Versus Thoracic Aortic Stiffness With Aging In Primates

Metabolic syndrome-associated murine aortic wall stiffening is associated with premature elastic fibers aging